BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27421659)

  • 1. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
    Qin B; Liu J; Liu S; Li B; Ren J
    Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells.
    Haque R; Hur EH; Farrell AN; Iuvone PM; Howell JC
    Mol Vis; 2015; 21():224-35. PubMed ID: 25802486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of miR-200b on retinal endothelial cell function under high glucose environment.
    Jiang Q; Zhao F; Liu X; Li R; Liu J
    Int J Clin Exp Pathol; 2015; 8(9):10482-7. PubMed ID: 26617758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
    McArthur K; Feng B; Wu Y; Chen S; Chakrabarti S
    Diabetes; 2011 Apr; 60(4):1314-23. PubMed ID: 21357793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-7 regulates the PI3K/AKT/VEGF pathway of retinal capillary endothelial cell and retinal pericytes in diabetic rat model through IRS-1 and inhibits cell proliferation.
    Cao YL; Liu DJ; Zhang HG
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4427-4430. PubMed ID: 30058674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
    Liu X; Li J; Li X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating
    Zhang ZZ; Qin XH; Zhang J
    Am J Physiol Endocrinol Metab; 2019 Jun; 316(6):E1050-E1060. PubMed ID: 30835506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI.
    Zhu K; Hu X; Chen H; Li F; Yin N; Liu AL; Shan K; Qin YW; Huang X; Chang Q; Xu GZ; Wang Z
    EBioMedicine; 2019 Nov; 49():341-353. PubMed ID: 31636010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANRIL: A Regulator of VEGF in Diabetic Retinopathy.
    Thomas AA; Feng B; Chakrabarti S
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):470-480. PubMed ID: 28122089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of miR-20b-5p Exerts Inhibitory Effect on Diabetic Retinopathy via Inactivation of
    Ma Y; Dong C; Chen X; Zhu R; Wang J
    Diabetes Metab Syndr Obes; 2021; 14():1183-1193. PubMed ID: 33758526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG7 inhibits high glucose-induced human retinal endothelial cells angiogenesis by regulating miR-543/SIRT1 axis.
    Ke N; Pi LH; Liu Q; Chen L
    Biochem Biophys Res Commun; 2019 Jun; 514(2):503-509. PubMed ID: 31056258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
    Gong Q; Li F; Xie J; Su G
    Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina.
    Wang Q; Bozack SN; Yan Y; Boulton ME; Grant MB; Busik JV
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3986-94. PubMed ID: 24867582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
    Jiang S; Chen X
    Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.